The TCM Etiology, Pathogenesy and Differential Treatment for Sjogren’s Syndrome

被引：3
|
作者：
张水艳 [1 ]
机构：
[1] Heibei Yiling Hospital, Shijiazhuang
来源：
JournalofTraditionalChineseMedicine | 2011年 / 31卷 / 01期
关键词：
body; The TCM Etiology; s Syndrome; Pathogenesy and Differential Treatment for Sjogren; TCM;
D O I：
暂无
中图分类号：
R259 [现代医学内科疾病];
学科分类号：
100506 ;
摘要：
Sjogren’s syndrome (SS) is a chronic inflammatory autoimmune disease, affecting mainly the exocrine glands, such as salivary gland and lacrimal gland. Clinically, the patients often have dry mouth and eyes, with swelling of the parotid gland, and pain of the joints. The condition may be different in individual patients,
引用
收藏
页码：73 / 78
页数：6
相关论文
共 50 条
  • [41] Rituximab treatment in patients with primary Sjogren's syndrome
    Pijpe, J
    van Imhoff, GW
    Spijkervet, FKL
    Roodenburg, JLN
    Wolbink, GJ
    Mansour, K
    Vissink, A
    Kallenberg, CGM
    Bootsma, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2740 - 2750
  • [42] Sjogren's syndrome: models of pathogenesis and treatment targets
    Derk, CT
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (11) : 1587 - 1594
  • [43] Oral Manifestations and Treatment of a Child With Sjogren's Syndrome
    Sardenberg, Fernanda
    Goursand, Daniela
    Polletto, Luiz Thadeu
    Vale, Miriam Pimenta
    Zarzar, Patricia Maria
    Paiva, Saul Martins
    JOURNAL OF DENTISTRY FOR CHILDREN, 2010, 77 (02): : 102 - 105
  • [44] Sjogren's Syndrome: Early diagnosis and effective treatment
    Witte, Torsten
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (24) : 1778 - 1782
  • [45] Effectiveness of Rituximab Treatment in Primary Sjogren's Syndrome
    Dejaco, Christian
    Duftner, Christina
    JOURNAL FUR MINERALSTOFFWECHSEL, 2010, 17 (02): : 85 - +
  • [46] The future of biologic agents in the treatment of Sjogren's syndrome
    Meijer, Jiska M.
    Pijpe, Justin
    Bootsma, Hendrika
    Vissink, Arjan
    Kallenberg, Cees G. M.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2007, 32 (03) : 292 - 297
  • [47] Is it the end of the road for abatacept treatment in Sjogren's syndrome?
    Fisher, Benjamin A.
    LANCET RHEUMATOLOGY, 2020, 2 (03): : E125 - E126
  • [48] Sjogren's syndrome and aromatase inhibitors treatment: is there a link?
    Guidelli, G. M.
    Martellucci, I.
    Galeazzi, M.
    Francini, G.
    Fioravanti, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : 653 - 654
  • [49] Use of muscarinic agonists in the treatment of Sjogren's syndrome
    Fox, RI
    Konttinen, Y
    Fisher, A
    CLINICAL IMMUNOLOGY, 2001, 101 (03) : 249 - 263
  • [50] Immunological consequences of thalidomide treatment in Sjogren's syndrome
    Moutsopoulos, NM
    Angelov, N
    Sankar, V
    Leakan, RA
    Pillemer, S
    Wahl, SM
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (01) : 112 - 114
12345